A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
Clinical trial NCT04571138 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04571138
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2025-08-08
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.